These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 6836987

  • 1. [Evaluation of the role of chemotherapy adjuvant to surgery in patients with cancer of the ovary, 1st stage].
    Nechaeva ID, Vinokurov VL, Nikolaeva DV, Livshits ME, Aĭnbinder NM.
    Vopr Onkol; 1983; 29(3):46-53. PubMed ID: 6836987
    [Abstract] [Full Text] [Related]

  • 2. Results of treatment of primary ovarian carcinoma.
    Saarikoski S, Selander K, Kauppila O, Raitala R, Pystynen P.
    Ann Chir Gynaecol; 1982; 71(3):156-60. PubMed ID: 7114781
    [Abstract] [Full Text] [Related]

  • 3. Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III/IV epithelial ovarian cancer.
    Everett EN, French AE, Stone RL, Pastore LM, Jazaeri AA, Andersen WA, Taylor PT.
    Am J Obstet Gynecol; 2006 Aug; 195(2):568-74; discussion 574-6. PubMed ID: 16890558
    [Abstract] [Full Text] [Related]

  • 4. [Advanced cancer of the ovary. Treatment and results].
    Wolff JP, George M, Duvillard P, Michel G, Pejovic MH, Haie C.
    J Gynecol Obstet Biol Reprod (Paris); 1986 Aug; 15(2):231-7. PubMed ID: 3722750
    [Abstract] [Full Text] [Related]

  • 5. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
    Trimbos JB, Vergote I, Bolis G, Vermorken JB, Mangioni C, Madronal C, Franchi M, Tateo S, Zanetta G, Scarfone G, Giurgea L, Timmers P, Coens C, Pecorelli S, EORTC-ACTION collaborators. European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm.
    J Natl Cancer Inst; 2003 Jan 15; 95(2):113-25. PubMed ID: 12529344
    [Abstract] [Full Text] [Related]

  • 6. Gynecological malignancies.
    Schaebler DL, Schilder RJ, Young RC.
    Cancer Chemother Biol Response Modif; 1996 Jan 15; 16():564-91. PubMed ID: 8639401
    [Abstract] [Full Text] [Related]

  • 7. High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results.
    Bertucci F, Viens P, Delpero JR, Bardou VJ, Faucher C, Houvenaeghel G, Maraninchi D.
    Bone Marrow Transplant; 2000 Jul 15; 26(1):61-7. PubMed ID: 10918406
    [Abstract] [Full Text] [Related]

  • 8. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG, Gershenson DM, Malpica A, Deavers M.
    Am J Surg Pathol; 2006 Nov 15; 30(11):1367-71. PubMed ID: 17063075
    [Abstract] [Full Text] [Related]

  • 9. Cost-effective treatment of women with advanced ovarian cancer by cytoreductive surgery and chemotherapy directed by an in vitro assay for drug resistance.
    Orr JW, Orr P, Kern DH.
    Cancer J Sci Am; 1999 Nov 15; 5(3):174-8. PubMed ID: 10367175
    [Abstract] [Full Text] [Related]

  • 10. Bowel resection at the time of primary debulking for epithelial ovarian carcinoma: outcomes in patients treated with platinum and taxane-based chemotherapy.
    Estes JM, Leath CA, Straughn JM, Rocconi RP, Kirby TO, Huh WK, Barnes MN.
    J Am Coll Surg; 2006 Oct 15; 203(4):527-32. PubMed ID: 17000397
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of radiotherapy for state I ovarian carcinoma].
    Sheng X, Sun J, Zhou C.
    Zhonghua Zhong Liu Za Zhi; 1996 Jul 15; 18(4):314-6. PubMed ID: 9387332
    [Abstract] [Full Text] [Related]

  • 12. [Cytoreductive surgery plus combined chemotherapy for the treatment of advanced ovarian cancer].
    Li M, Huang X.
    Zhonghua Fu Chan Ke Za Zhi; 1996 Oct 15; 31(10):621-3. PubMed ID: 9275460
    [Abstract] [Full Text] [Related]

  • 13. Adjuvant chemotherapy as treatment of high-risk stage I and II endometrial cancer.
    Aoki Y, Watanabe M, Amikura T, Obata H, Sekine M, Yahata T, Fujita K, Tanaka K.
    Gynecol Oncol; 2004 Aug 15; 94(2):333-9. PubMed ID: 15297170
    [Abstract] [Full Text] [Related]

  • 14. [Sequence of using the components of combined treatment in stage III and IV ovarian cancer patients and late treatment results].
    Zadontseva NS.
    Vopr Onkol; 1985 Aug 15; 31(7):68-72. PubMed ID: 4024563
    [Abstract] [Full Text] [Related]

  • 15. Dysgerminoma: the role of conservative surgery.
    Casey AC, Bhodauria S, Shapter A, Nieberg R, Berek JS, Farias-Eisner R.
    Gynecol Oncol; 1996 Dec 15; 63(3):352-7. PubMed ID: 8946871
    [Abstract] [Full Text] [Related]

  • 16. Treatment of ovarian cancer with paclitaxel- or carboplatin-based intraperitoneal hyperthermic chemotherapy during secondary surgery.
    Bae JH, Lee JM, Ryu KS, Lee YS, Park YG, Hur SY, Ahn WS, Namkoong SE.
    Gynecol Oncol; 2007 Jul 15; 106(1):193-200. PubMed ID: 17466362
    [Abstract] [Full Text] [Related]

  • 17. Epithelial ovarian cancer: impact of surgery and chemotherapy on survival during 1977-1990.
    Venesmaa P.
    Obstet Gynecol; 1994 Jul 15; 84(1):8-11. PubMed ID: 8008329
    [Abstract] [Full Text] [Related]

  • 18. Recent advances in the management of women with ovarian cancer.
    Eltabbakh GH.
    Minerva Ginecol; 2004 Feb 15; 56(1):81-9. PubMed ID: 14973412
    [Abstract] [Full Text] [Related]

  • 19. Factors influencing ovarian cancer survival after chemotherapy.
    Webb MJ, Malkasian GD, Jorgensen EO.
    Obstet Gynecol; 1974 Oct 15; 44(4):564-70. PubMed ID: 4413425
    [No Abstract] [Full Text] [Related]

  • 20. Endodermal sinus tumor of the ovary: the Hacettepe University experience.
    Ayhan A, Taskiran C, Bozdag G, Altinbas S, Altinbas A, Yuce K.
    Eur J Obstet Gynecol Reprod Biol; 2005 Dec 01; 123(2):230-4. PubMed ID: 16026921
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.